Objective: We describe a patient with seronegative autoimmune limbic encephalitis (SNALE) masquerading as glioma. Brain magnetic resonance imaging (MRI) abnormalities, distinctive pathological findings, and spontaneous remission are highlighted.
A utoimmune limbic encephalitis (LE) is characterized by an acute or subacute onset of encephalopathy, temporal lobe seizures, cognitive impairment, and neuropsychiatric disorders. 1, 2 Although the term LE is suggestive of predominate limbic involvement, extralimbic involvement may coexist. The pathophysiology of autoimmune LE is either paraneoplastic or nonparaneoplastic.
The paraneoplastic subtype of autoimmune LE is associated with antibodies targeting intracellular onconeural antigens (eg, Hu Abs, CV2/CRMP5 Abs, Ma2 Abs 1 ). Less frequently, antibodies targeting glutamic acid decarboxylase (GAD) or voltage-gated potassium channel (VGKC) complex in low titers may be present in paraneoplastic LE. 1 Antibodies targeting NR1/NR2B heteromers of N-methyl-D-aspartate receptors (NMDARs) are often associated with panencephalitis and not typically with LE. 1, 3 The inflammatory infiltrates caused by antibodies to intracellular antigens are more prominent compared with those of cell membrane antigens. 4 The nonparaneoplastic subtype is often associated with high titers of antibodies to VGKC complex. 1 In patients with high VGKC-complex-Abs titers, these antibodies seem to target associated VGKC-complex proteins instead of Kv1 subunits. 5 These targeted proteins are leucine-rich, glioma inactivated 1 (Lgi1), and contactin-associated protein-2 (Caspr2), with more prominent expression of Lgi1 in the mossy fiber layer of the hippocampal CA3 areas. 5 In patients with Lgi1-Abs, seizures are more common and neuromyotonia is less frequent compared with patients with Caspr2-Abs. 5 Less frequently, autoantibodies are directed at NMDARs 1, 3 or at intracellular antigens such as GAD. 1 More recently, antibodies targeting a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) and gamma aminobutyric acid-beta receptor (GABA B R) have been identified in association with LE. 1 Occasionally, nonparaneoplastic LE is also associated with an underlying systemic autoimmune disorder. Future studies will likely identify additional neural autoantigens associated with LE.
Seronegative autoimmune limbic encephalitis (SNALE) is a term reserved for a nonparaneoplastic, noninfectious subgroup of LE, in which immunological mechanisms are suspected clinically, but the targeted neural autoantigens are either unknown or uncharacterized. 6 We describe a case of SNALE masquerading as glioma, with distinctive clinical course and pathological changes.
MATERIALS AND METHODS

Case Report
A 66-year-old right-handed man presented with a few-week history of a prodromal viral-like illness that was characterized by intermittent mild low-grade fever, fatigue, nonspecific muscle aches, and mild diffuse headaches, which were followed by progressive short-term memory impairment and complex partial seizures averaging 1 seizure per day. The seizures began with "a dreamy state" followed by motionless staring and unresponsiveness for several minutes. The patient was started on phenytoin. Past medical and neurologic histories were unremarkable. There were no earlier symptoms of cognitive or affective disorders. The patient had completed 2 years of undergraduate schooling and subsequently ran his own business.
RESULTS
Initial brain magnetic resonance imaging (MRI) on T2-weighted image (T2-wi) and fluid-attenuated inversion recovery (FLAIR) sequence showed marked left mesial temporal lobe hyperintensity. Cerebrospinal fluid (CSF) was normal. Screening for infectious agents in the CSF and serum was negative. He was treated empirically with 3-week intravenous acyclovir, without improvement.
Five weeks after the onset, he was admitted to our institution for refractory seizures. Medical examination was normal, without signs of infections or systemic autoimmune disorders. On neurologic examination, performed by an epileptologist, the patient was alert and oriented to person, place, and time and had a profound short-term memory deficit. The patient was able to recall 0 out of 3 items at 15 seconds (Fig. 4) . Verbal fluency was normal with no paraphasic errors or obvious word-finding difficulty. He was able to follow 3 simple stage commands. Praxis was normal. There were no signs of meningismus or encephalopathy. Fundoscopic examination was benign. The segmental neurological examination was entirely normal. No signs of autonomic instability, spontaneous or action-induced myoclonus, or any other muscle twitches to suggest neuromyotonia were noted. Levetiracetam and valproate were added.
Repeat brain MRI, performed with and without gadolinium, showed a contrast-enhancing hyperintensity lesion on T2-wi/FLAIR in the left uncus and hippocampal formation (Fig. 1AÀC) , with minimal mass effect (Fig. 1A, B) . These findings were initially thought to represent a glioma. A subtle right anterior mesial temporal lobe hyperintensity on T2-wi/FLAIR went undetected at the time (Fig. 1A, B) . Electroencephalogram showed left temporal focal slowing and epileptiform sharp activity. Wada test demonstrated left hemispheric language dominance and right hemispheric memory dominance.
Stereotactic resection of the left mesioanterior temporal lobe was performed 6 weeks after the onset. Pathologic findings in the mesial temporal structures, cortex, and white matter included focally intense perivascular and parenchymal inflammatory infiltrates of T lymphocyte and slightly predominate B lymphocyte subtypes ( Fig. 2A, B, Fig. 2F , G), prominent microglia nodules (Fig. 2B , C), and neuronophagia (Fig. 2D ). There were rare lymphocytes within neurons (emperipolesis) (Fig. 2E ). Immunostains for viruses (including HSV and cytomegalovirus), bacteria, fungi, and spirochetes were all negative. Repeat CSF analysis revealed no pleocytosis, normal glucose level, and elevated protein concentration (170 mg/dL). Negative CSF and serologic tests included Cryptococcus neoformans, Borrelia burgdorferi, syphilis, and a comprehensive antiviral antibody panel for HSV-1, HSV-2, HHV-6, varicella zoster, cytomegalovirus, Coxsackie, Echo, Epstein-Barr, influenza, measles, mumps, Rubella, HIV-1, and HIV-2. Polymerase chain reaction testing for HSV-1, HSV-2, and varicella zoster was negative. Negative serologic screening for systemic autoimmune disorders included ANA, anti-dsDNA, antineutrophilic cytoplasmic antibodies, Sjogren's antibodies, antithyroglobulin, thyroid peroxidase antibody, C3, C4, CH50, and antiphospholipid. Tests for autoantibodies targeting VGKC-complex, GAD, and onconeural antigens (eg, Hu Abs, Ma2 Abs, CV2/CRMP5 Abs) were negative. Whole-body computed tomography scan revealed no occult malignancy.
Postoperatively, the patient was seizure-free for only 6 weeks, after which point seizures recurred. The frequency of complex partial seizures progressed to 4 to 6 per day, with an associated prominent amnestic syndrome. The patient's seizures were refractory to more than 5 antiepileptic drugs. Repeat brain MRI, with and without gadolinium enhancement, revealed a new enhancing lesion in the right mesial temporal structures (Fig.  3A, B) . Repeat serological screening for autoimmune antibodies remained negative. Formal neuropsychological evaluation (Fig. 4) showed profound impairment of verbal and visual memory. Immediate and delayed recall of a word list was at the first percentile or below. Immediate recall of contextual verbal information was at the 37th percentile, whereas delayed recall of the same 
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of visual attention was problematic. Visual perceptual abilities were impaired. Nonverbal abstract reasoning ability and symbol reproduction were both at the 16th percentile. Performance on a block design task was at the second percentile, and his ability to copy a complex figure was below the first percentile. Cognitive flexibility was intact. He was able to maintain a problem-solving strategy and able to shift his strategy when the task demanded change. Superimposed depression was noted. A diagnosis of SNALE was entertained. The family declined steroids or intravenous immunoglobulin. Repeat brain MRI 14 weeks postoperatively demonstrated dramatic improvement of the enhancing lesion (Fig. 3E,  F) , accompanied by full seizure control. In addition, there was significant improvement of cognitive function with only mildly improved memory functions (the patient was able to recall 1 out of 3 items at 15 and 30 s and 0 out of 3 items at 3 min) demonstrated by neurological/cognitive examination that was completed by the same epileptologists who performed the initial evaluation (Fig. 4) . A 3-year postoperative brain MRI showed a subtle residual FLAIR signal abnormality and complete resolution of enhancement of the right mesial temporal lobe (Fig. 3G,  H) . Without immune therapy, during the follow-up of 8 years, he continued to report slow but steady improvement of his general cognitive function, whereas improvement of short-term/long-term memory deficits was less evident. The patient declined repeat formal neuropsychological testing. However, on his most recent neurological examination, he was able to recall 2 out of 3 items at 30 seconds and 1 out of 3 items at 3 and 15 minutes (Fig. 4) . He had fluent speech with no paraphasic errors, but with mild word-finding difficulty. Processing speed and abstract reasoning were improved. He showed high levels of anxiety, frustration, and mild depression. The segmental neurologic examination remained unremarkable. His seizures are controlled on a low dose of lamotrigine. A chronological timeline of the aforementioned clinical course and diagnostic tests is summarized in Figure 4 .
DISCUSSION
Our case documents spontaneous remission of clinical and neuroimaging abnormalities in SNALE, without immune therapy. The diagnosis of SNALE is supported by (1) pathology documenting inflammation without virus or other pathogens, (2) no relapse or evidence of an occult tumor over 8 years excluding paraneoplastic LE, (3) negative CSF and serological viral studies, (4) negative tests for serum autoantibodies, including VGKC-complex Abs and GADAbs, and (5) MRI abnormalities confined to the mesial temporal structures.
Our case is unusual because of (i) the MRI abnormalities mimicking glioma, (ii) the spontaneous remission without immune therapy, and (iii) the distinctive pathological findings.
In 15 previous reports of SNALE (Table 1) , 6 -11 the clinical presentations were similar to other cases of autoimmune LE. In addition, brain MRI reports consistently revealed hyperintense signal changes in the hippocampus, often bilaterally, without enhancement (Table 1) . [6] [7] [8] [9] [10] [11] The sequential bilateral enhancement observed in our case (Fig. 1C, Fig. 3B ), however, has not been described in previous published cases of SNALE (Table 1) .
The response to immune therapy in SNALE cases varies from full recovery (Table 1) 6,8,9,11 to limited improvement of cognitive and behavioral functions and seizures (Table 1) . 6, 10 Although in our patient, clinical remission and spontaneous resolution of the right mesial temporal encephalitis may raise doubt regarding the efficacy of immune therapy in SNALE, this single observation is insufficient evidence to refute its therapeutic role. Moreover, early initiation of immune therapy may have halted the immunological process, thereby preventing the sequential involvement of the right mesial temporal lobe.
Some of the previously reported cases of SNALE may have resulted from autoantibodies targeting newly defined autoantigens, such as GluR1/GluR2 subunits of the AMPAR and GABA B R. 1 In our case, testing for autoantibodies targeting NMDAR, AMPAR, or GABA B R was not performed, as these were not available in 2002. However, the pathological changes in our case are distinct from the limited available pathologic data describing cases of known cell membrane autoimmunity, such as those with antibodies targeting VGKC complex 4, [12] [13] [14] [15] or NMDAR. 16 Pathology reports of VGKC-complex-Abs-related LE document focal neuronal loss of the CA4 region and 12 scattered parenchymal and focal perivascular infiltrates with neither neuronophagia nor microglia nodules. [12] [13] [14] [15] In NMDAR-Abs-related encephalitis, despite florid IgG deposits, the inflammatory changes are even milder, characterized by some microglia activation with neither neuronophagia nor microglial nodules. 16 In our case, by contrast, there was more focally intense perivascular and diffuse parenchymal mixed lymphocytic infiltrates ( Fig.  2A, B, Fig. 2F, G) , with both prominent microglial nodules (Fig. 2B, C) and neuronophagia (Fig. 2D) .
In the sole previous case of SNALE with neuropathological data, the disorder was fatal owing to limbic and extralimbic brain inflammatory changes. 7 The severity was attributed to the patient's comorbidities: thymectomy for myasthenia gravis and relapsing polychondritis. 7 The pathologic finding of lymphocyte emperipolesis within neurons (Fig. 2E ) in our case is a rare phenomenon that we could not find previously described in any autoimmune encephalitis, including LE subtypes. Emperipolesis in human brains can involve oligodendrocytes within astrocytes (eg, demyelinating disease), 17 lymphocytes within histiocytes (eg, Rosai-Dorfman disease), 18 lymphocytes within astrocytes (eg, multiple sclerosis and brain tumors), 19 and lymphocytes within oligodendrocytes (eg, experimental autoimmune encephalomyelitis). 20 One animal study reported lymphocyte emperiopolesis within neurons, induced by intraneural injection of ricin. 21 The significance of lymphocyte emperiopolesis in our case is uncertain. It may represent a form of neuronal toxicity by overstimulated lymphocytes. 21 In summary, an acute or subacute presentation of a prodromal viral-like illness followed by cognitive dysfunction with behavioral or psychiatric manifestations, and/or seizures, should raise the clinical suspicion of autoimmune LE, notwithstanding the absence of serum autoantibodies. 9, 22 Diagnostic tests, such as brain MRI or single photon emission computed tomography scan, both of which may reveal bilateral hippocampal involvement, electroencephalogram, and CSF analysis, can be helpful in corroborating the diagnosis of SNALE. If the diagnosis remains uncertain, then the demonstration of a significant response to immune therapy trials (eg, corticosteroids, intravenous immunoglobulin) may be confirmatory. Given the absence of data describing the incidence of spontaneous remission of SNALE and that other researchers have emphasized the importance of immunotherapy in SNALE 9 and NMDA encephalitis, 16 future studies of SNALE clarifying both its natural course and the role of immunotherapy are needed. Therefore, in the absence of such studies, notwithstanding the spontaneous resolution of the right mesial temporal encephalitis in our patient, we advocate initiating immune therapy early, to optimize neurological, neuropsychiatric, and cognitive outcomes. In planning future clinical trials aimed at assessing the efficacy of immune therapy in SNALE, researchers should consider the possibility that spontaneous resolution without treatment may occur. Clinically, this case highlights that (1) SNALE may be underdiagnosed; (2) the absence of positive autoantibody tests should not exclude SNALE; (3) the need to recognize that SNALE may masquerade as gliomas, to avoid unwarranted resective surgery; and (4) SNALE can spontaneously resolve without therapy.
